Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI (PRIMERI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01353131|
Recruitment Status : Unknown
Verified September 2015 by Joao A.C Lima, Johns Hopkins University.
Recruitment status was: Active, not recruiting
First Posted : May 12, 2011
Last Update Posted : September 2, 2015
|Condition or disease|
|Inpatients and Outpatients With Routine 12-lead ECG|
|Study Type :||Observational|
|Estimated Enrollment :||160 participants|
|Official Title:||Personalized Risk Identification and Management for Arrhythmias and Heart Failure by 12 Lead Electrocardiogram and Cardiac Magnetic Resonance Imaging.|
|Study Start Date :||May 2010|
|Estimated Primary Completion Date :||September 2016|
|Estimated Study Completion Date :||October 2016|
1000 patients with moderate to high risk determined by stratification algorithm based on the electronic analysis of 69,088 routine 12-lead ECGs performed in a large medical institution during a 6 month period by combining previously established indices of abnormal repolarization (wide QRS-T angle) with validated measures of myocardial damage (Selvester QRS score) excluding those > 70 years of age or with LV ejection fraction ≤ 35%, or at a high risk of dying within 3 years from cancer, end stage cardiac, pulmonary, renal, immunologic or neurologic diseases excluded on clinical data obtained through medical record.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01353131
|United States, Maryland|
|Division of Cardiology, Johns Hopkins University School of Medicine|
|Baltimore, Maryland, United States, 21287|
|Principal Investigator:||Joao AC Lima, MD, PhD||Johns Hopkins University|